{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:47:08Z","timestamp":1787014028653,"version":"build-2736575974"},"reference-count":40,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81825008"],"award-info":[{"award-number":["81825008"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["CNS Neurosci Ther"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To assess the temporal changes in the characteristics of ischemic stroke drug clinical trials conducted in mainland China in 2005\u20132021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A statistical analysis of registered clinical trials on ischemic stroke was performed using the platform of the Center for Drug Evaluation of China National Medical Products Administration, the Chinese Clinical Trial Registry, and\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                      websites.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From January 1, 2005 to August 1, 2021, a total of 384 registered drug clinical trials on ischemic stroke were identified in mainland China. Over time, the number of trials gradually increased each year, with a significant growth in 2014, from 16 in 2013 to 42 in 2014. Phase IV trials (31.8%) accounted for the majority, followed by phase II (16.4%), phase I (10.9%), and phase III (8.6%). In terms of sponsorship, the proportion of investigator\u2010initiated trials (IITs) (60.7%) was higher than industry\u2010sponsored trials (ISTs) (39.3%). Additionally, trials involving traditional Chinese medicines (TCMs) (36.2%) accounted for the largest proportion, followed by trials involving antithrombotic therapy (19.5%) and cerebral protection agents (16.7%). Furthermore, over the past 17\u2009years, the number of leading drug clinical trial units for ischemic stroke in mainland China has continuously increased. The leading principal units from Beijing, Shanghai, Guangdong, Jiangsu, and Liaoning accounted for the majority of the trials (67.4%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the past 17\u2009years, great progress has been made in the research and development (R&amp;D) of drugs and clinical trials for ischemic stroke in mainland China. The most extensive progress was observed in TCMs, antithrombotic therapy, and cerebral protection agents. More clinical trials are needed to confirm whether the newly developed drugs can improve the clinical efficacy of ischemic stroke. Simultaneously, more pharmaceutical R&amp;D efforts of innovative drugs are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/cns.13867","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T07:44:24Z","timestamp":1654069464000},"page":"1229-1239","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evolution of ischemic stroke drug clinical trials in mainland China from 2005 to 2021"],"prefix":"10.1111","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6131-4105","authenticated-orcid":false,"given":"Chunrui","family":"Bo","sequence":"first","affiliation":[{"name":"Department of Neurology, XuanWu Hospital Capital Medical University  Beijing China"},{"name":"Department of Neurology, The Second Affiliated Hospital Harbin Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, XuanWu Hospital Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengbei","family":"Hou","sequence":"additional","affiliation":[{"name":"Center for Evidence\u2010Based Medicine, Xuanwu Hospital Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6084-3275","authenticated-orcid":false,"given":"Jinming","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Neurology, XuanWu Hospital Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital Harbin Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital Harbin Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2782-4010","authenticated-orcid":false,"given":"Lihua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital Harbin Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Department of General Surgery, China National Clinical Research Center for Geriatric Diseases, XuanWu Hospital Capital Medical University  Beijing China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,6]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.025250"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2016.11.006"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1747-4949.2010.00460.x"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056459"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.192535"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25235"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00132-5"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.013713"},{"issue":"09","key":"e_1_2_10_10_1","first-page":"666","article-title":"Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018 (in Chinese)","volume":"51","author":"Chinese Socity of neurology, Chinese stroke society","year":"2018","journal-title":"Chin J Neurol"},{"key":"e_1_2_10_11_1","unstructured":"The State Council of the People's Republic of China.State Council's opinions on reforming the examination and approval system for drug and medical devices (in Chinese).2015:22\u201325.http:\/\/www.gov.cn\/zhengce\/content\/2015\u201008\/18\/content_10101.htm. Accessed 2015\/09\/10. [Updated November 03 2021]."},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1177\/1747493020913557"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l879"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000182100.65262.46"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X211058261"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2021.1985463"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.721156"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2020.113518"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23010014"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21197380"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.120.029749"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1177\/0271678X18807309"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.743926"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.200"},{"key":"e_1_2_10_25_1","unstructured":"General Office of the State Council of the People's Republic of China.Opinions on deepening reforms on the drug review system to encourage the innovation for drug and medical equipment (in Chinese).2017.http:\/\/www.gov.cn\/zhengce\/2017\u201010\/08\/content_5230105.htm. [Updated November 03 2021. 9\u201313]"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2021.100151"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2021.100097"},{"issue":"4","key":"e_1_2_10_28_1","first-page":"391","article-title":"Implementing the strategy of 'Healthy China' and strengthening the setting\u2010up of National Demonstration Areas, for comprehensive prevention and control of non\u2010communicable diseases","volume":"39","author":"Jiang Y","year":"2018","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004056"},{"key":"e_1_2_10_30_1","unstructured":"Center for Drug Evaluation of National Medical Products Administration.Technical guidelines for clinical research on new traditional Chinese medicine in the treatment of stroke (in Chinese).https:\/\/www.cde.org.cn\/zdyz\/domesticinfopage?zdyzIdCODE=55a2bda21de2cb172171c71120d78229. Accessed 2015\/11\/03. [Updated November 03 2021]."},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2003.09.004"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pep.2005.06.009"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.3_Suppl_3.S53"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2021-000978"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1215340"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0000000000000024"},{"issue":"13","key":"e_1_2_10_37_1","first-page":"10","article-title":"The Chinese experiment rewriting international guidelines","volume":"28","author":"CHANCE Research","year":"2013","journal-title":"Chin Med News"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1136\/svn-2020-000791"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/1747493017694390"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.014413"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/cns.13724"}],"container-title":["CNS Neuroscience &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cns.13867","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cns.13867","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cns.13867","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T01:18:16Z","timestamp":1704935896000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cns.13867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1111\/cns.13867"],"URL":"https:\/\/doi.org\/10.1111\/cns.13867","archive":["Portico"],"relation":{},"ISSN":["1755-5930","1755-5949"],"issn-type":[{"value":"1755-5930","type":"print"},{"value":"1755-5949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"2022-02-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}